Breast Carcinoma Clinical Trials in Ann Arbor, Michigan

6 studies are recruiting for breast carcinoma in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

   This phase III trial compares the effect of vaginal fractional CO2 laser therapy to placebo for the treatment of vaginal dryness in breast cancer survivors with symptoms of genitourinary syndrome of menopause (GSM). Placebo therapy is an inactive treatment that is designed to mimic as closely as po…

   Stage

   Phase 3

   Ages

   22 and older

   Site

   Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor, Michigan

   Locations

   2 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT05379153 on ClinicalTrials.gov

2. Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

   This phase II trial evaluates tamoxifen, with or without omega-3 fatty acids, for reducing risk of breast cancer among postmenopausal and overweight or obese women who are at increased risk of developing breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works by blocking the e…

   Stage

   Phase 2

   Ages

   45 to 74

   Site

   University of Michigan Rogel Cancer Center, Ann Arbor, Michigan

   Locations

   3 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT06195306 on ClinicalTrials.gov

3. Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

   This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works …

   Stage

   Phase 2

   Ages

   18 to 55

   Site

   University of Michigan Rogel Cancer Center, Ann Arbor, Michigan

   Locations

   11 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT06184750 on ClinicalTrials.gov

4. CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

   This clinical trial studies how well a chemotherapy-induced peripheral neuropathy (CIPN) decision aid works in improving chemotherapy decision making among patients with breast cancer. CIPN involves numbness or tingling in the hands or feet and is a debilitating side effect of several commonly used…

   Stage

   Not phased

   Ages

   Any age

   Site

   University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

   Run by

   University of Michigan Rogel Cancer Center

   See if you can join NCT06915168 on ClinicalTrials.gov

5. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

   This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan

   Locations

   467 in total

   Run by

   Wake Forest University Health Sciences

   See if you can join NCT06418204 on ClinicalTrials.gov

6. A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

   This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, …

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

   Run by

   University of Michigan Rogel Cancer Center

   See if you can join NCT07291414 on ClinicalTrials.gov